More water = lower concentration: Makes it way easier to measure small doses precisely
If you cannot tolerate GLP-1 agonists, have only modest fat loss goals, or want to add a well-tolerated compound to an existing protocol, AOD 9604 might have a place
Based on the available evidence, cagrilintide appears to have a more favorable body composition profile, though the magnitude of difference between the two compounds remains to be determined through direct comparison studies
Directions are clear and concise
Description Overview 5-Amino-1MQ is a selective NNMT inhibitor that elevates cellular NAD+ and SAM to enhance mitochondrial function, fat oxidation, insulin sensitivity, and overall metabolic efficiency, with preclinical data indicating preferential visceral fat loss and a favorable safety profile